| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |